tm logo
IMULYTIC
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 28 Jun 2024

Last Applicant/ Owned by

Milton Park, Abingdon

Oxfordshire

GB

OX144RQ

Serial Number

87322931 filed on 02th Feb 2017

Registration Number

5353766 registered on 12th Dec 2017

in the Principal Register

Correspondent Address

Melanie Howard, Esq.

MELANIE HOWARD, ESQ. LOEB & LOEB LLP

LOS ANGELES, CA 90067-4120

UNITED STATES

Filing Basis

1. intent to use

Disclaimer

NO DATA

IMULYTIC

Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; viruses for the treatment of cancer and tumors; viruses for inducing immune response for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceutical preparations and ph Read More

Classification Information


Class [005]
Pharmaceutical Products


Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; viruses for the treatment of cancer and tumors; viruses for inducing immune response for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceutical preparations and pharmaceutical substances for the treatment of infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceutical preparations and pharmaceutical substances used for the prevention and treatment of cancer and tumors; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response for the treatment of cancer and tumors; vaccines; immunotherapy products, namely, pharmaceuticals for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 87322931

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 221834-00007

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
28th Jun 2024CANCELLED SEC. 8 (6-YR)
12th Dec 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14th Feb 2019CORRECTION UNDER SECTION 7 - PROCESSED
14th Feb 2019ASSIGNED TO PARALEGAL
13th Feb 2019REPRINTING REGISTRATION CERTIFICATE
06th Nov 2018POST REGISTRATION ACTION MAILED - SEC. 7
15th Oct 2018OTQR WITHDRAWAL FROM PUBLICATION
15th Oct 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Sep 2018POST REGISTRATION ACTION CORRECTION
10th Sep 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED